1162565

WES Pharma Inc. — FEI 3010062344

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 18, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Westminster, MD (United States)